Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.40
+0.06 (0.82%)
Dec 30, 2025, 4:00 PM EST - Market closed
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $218.66 million as of December 31, 2025. Its market cap has increased by 19.35% in one year.
Market Cap
218.66M
Enterprise Value
198.23M
1-Year Change
19.35%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $218.66M, an increase of 92.48%. That is a compound annual growth rate of 11.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 221.30M | 19.49% |
| Dec 31, 2024 | 185.20M | 2.09% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
| Oct 30, 2019 | 113.60M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |